NEW YORK (GenomeWeb) – Premaitha Health said today that it has signed an agreement under which Thermo Fisher Scientific will provide it with a £5 million ($7.6 million) loan. The UK-based noninvasive prenatal test provider also reported £0.6 million in revenues for the first half of its fiscal year 2016 today.

Thermo Fisher will invest £5 million in Premaitha as a secured loan facility, of which the company will receive £3 million initially and the remainder as milestone payments over the next two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.